Want to join the conversation?
Biopharmaceutical company $SPHS said it has closed its previously announced public offering. With the proceeds from the offering, company plans to conduct a second Phase 2 clinical trial of topsalysin for treating localized prostate cancer. Company expects to have 6 month biopsy data from the trial in 2H of 2017.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?